MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin
Clinical trial NCT01792518 · COMPLETED
Trial details
- NCT number
- NCT01792518
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2015-11-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.